Sickle cell disease: selected aspects of pathophysiology

Area of Science:

• Hematology
• Genetics
• Neurology

Background:

• Sickle cell disease (SCD) is a genetic disorder caused by a specific amino acid substitution in hemoglobin, leading to abnormal blood flow and painful crises.
• Sickle cell trait (SCT) is a milder, typically benign variant with a single affected beta-chain.
• Existing research on SCD and SCT lacks comprehensive data on neurological function and transfusion therapy.

Purpose of the Study:

• To provide an overview of neurological function and transfusion therapy in sickle cell disease and trait.
• To discuss the roles of hypoxia, autonomic nervous system regulation, and blood rheology in disease manifestation.
• To examine the potential link between these factors and sudden death.

Main Methods:

• Literature review and synthesis of existing studies on SCD and SCT.
• Analysis of the impact of hypoxia, autonomic nervous system regulation, and blood rheology.
• Exploration of potential correlations with sudden death events.

Main Results:

• Neurological function and transfusion therapy in SCD and SCT remain incompletely understood.
• Hypoxia, autonomic nervous system regulation, and blood rheology are identified as key factors influencing clinical manifestations.
• A possible causal relationship between these factors and sudden death warrants further investigation.

Conclusions:

• Further research is essential to elucidate the roles of hypoxia, autonomic nervous system regulation, and blood rheology in SCD and SCT.
• Such studies are anticipated to enhance understanding of disease pathophysiology.
• Improved clinical management and quality of life for patients with SCD and SCT are expected outcomes.